These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33 related articles for article (PubMed ID: 3628278)
21. Effects of beta-funaltrexamine in normal and morphine-dependent rhesus monkeys: observational studies. Gmerek DE; Woods JH J Pharmacol Exp Ther; 1985 Nov; 235(2):296-301. PubMed ID: 4057071 [TBL] [Abstract][Full Text] [Related]
22. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine. Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843 [TBL] [Abstract][Full Text] [Related]
24. Pharmacological characterization in vivo of the novel opiate, beta-funaltrexamine. Ward SJ; Portoghese PS; Takemori AE J Pharmacol Exp Ther; 1982 Mar; 220(3):494-8. PubMed ID: 6121045 [TBL] [Abstract][Full Text] [Related]
25. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition. Liu-Chen LY; Yang HH; Li S; Adams JU J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074 [TBL] [Abstract][Full Text] [Related]
26. Intrathecal beta-funaltrexamine (beta-FNA) is a long acting agonist in the mouse abdominal stretch test. Heyman JS; Porreca F Proc West Pharmacol Soc; 1987; 30():209-10. PubMed ID: 3628278 [No Abstract] [Full Text] [Related]